Shortening the course of antibiotic treatment in the intensive care unit

Area of Science:

• Critical Care Medicine
• Infectious Diseases
• Pharmacology

Background:

• Antimicrobial stewardship is crucial globally.
• Prolonged antibiotic courses for sepsis in the ICU lack evidence and may cause harm.
• Current guidelines often recommend 10–14 days of antibiotics, but shorter durations may suffice.

Purpose of the Study:

• To evaluate the feasibility and safety of reducing antibiotic course lengths for intensive care unit (ICU) patients with sepsis.
• To identify preconditions for safely shortening antibiotic durations.

Main Methods:

• Review of existing evidence on antibiotic durations for sepsis.
• Discussion of necessary measures for safe de-escalation of antibiotic therapy.
• Consideration of biomarkers like procalcitonin for guiding treatment duration.

Main Results:

• Evidence suggests that substantially shorter antibiotic courses (less than 7 days) may be effective for ICU sepsis.
• Preconditions for safe reduction include septic foci eradication and optimized antibiotic concentrations.
• Biomarkers such as procalcitonin can aid in decision-making.

Conclusions:

• Short antibiotic courses can likely be safely administered to most ICU patients with infections.
• Close patient monitoring in critical care settings facilitates safe reduction of antibiotic duration.
• Optimized antimicrobial therapy and biomarker use are key to effective stewardship.